CRVS vs JBIO: stock comparison and AI forecast
Corvus Pharmaceuticals, Inc. (CRVS) and Jade Biosciences, Inc. (JBIO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CRVS Corvus Pharmaceuticals, Inc.
- Price
- $10.57 -31.6% · 6M
- Market Cap
- $889M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
JBIO Jade Biosciences, Inc.
- Market Cap
- $894M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CRVS and JBIO have similar market capitalizations ($889M and $894M).
- JBIO carries 0.07 times debt per unit of equity, against 0.06 times for CRVS.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CRVS | JBIO |
|---|---|---|
| Market Cap | $889M | $894M |
| P/B Ratio | 3.95x | 2.03x |
| EPS | $-0.62 | $-3.00 |
| Book Value/Share | $2.68 | $6.92 |
| FCF/Share | $-0.54 | – |
Profitability & Margins
| Metric | CRVS | JBIO |
|---|---|---|
| ROE | -24.0% | -42.9% |
| ROA | -22.6% | -40.0% |
| ROIC | -25.2% | -41.9% |
| Tax Rate | 0.0% | -0.1% |
Financial Health
| Metric | CRVS | JBIO |
|---|---|---|
| Current Ratio | 16.16x | 14.93x |
| D/E Ratio | 0.06x | 0.07x |
| Financial Leverage | 1.06x | 1.07x |
| Working Capital | $207M | $440M |
Cash Flow
| Metric | CRVS | JBIO |
|---|---|---|
| Operating Cash Flow | -$45M | -$124M |
| Free Cash Flow | -$45M | – |
| Capital Spending | -$700K | – |
Income Statement
| Metric | CRVS | JBIO |
|---|---|---|
| Operating Income | -$57M | -$185M |
| Net Income | -$54M | -$189M |
| R&D Expense | $46M | $157M |
Dividend & Shareholder Information
| Metric | CRVS | JBIO |
|---|---|---|
| Shares Outstanding | 84M | 64M |
CRVS vs JBIO: stock comparison and AI forecast
Which is bigger, CRVS or JBIO?
CRVS and JBIO have similar market capitalizations ($889M and $894M).
Which one does Intratio's AI model rank higher, CRVS or JBIO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.